CLYDE PHARMACY LIMITEDActive

Company number SC273095Private limited companyIncorporated 2004

Key figures

£1,773,085+6.9%
Net assets 2024/25
+8.0%
Average annual growth 2019/20–2024/25
0500 k1 m1.5 m2 m2019/202020/212021/222022/232023/242024/25

Like most small UK companies, CLYDE PHARMACY LIMITED does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.

Ratios

2024/25
Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
01 m2 m2019/202020/212021/222022/232023/242024/25
Filed accounts2019/20–2024/25
2020/212021/222022/232023/242024/25
Cash at bank and in hand1,123,8621,245,6431,306,5621,391,2401,538,744
Total assets1,694,9051,704,6361,809,1761,872,8451,954,237
Total liabilities————181,152
Net assets / total equity1,346,3781,490,5891,582,2401,658,9481,773,085
Average number of employees131110100

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Summary: CLYDE PHARMACY LIMITED

Company

CLYDE PHARMACY LIMITED is a private limited company registered with Companies House under company number SC273095. It was incorporated on 8 Sep 2004. Its status is active. The registered office is in Kilmacolm (PA13). Its nature of business (SIC 2007) is dispensing chemist in specialised stores (47730).

Accounts

The latest accounts in the database are for 2024/25 (period ending 30 Sep 2025); the company files small company accounts (filleted). Net assets were £1,773,085, up 6.9% on the previous year. Cash at bank and in hand was £1,538,744. Total assets were £1,954,237 and total liabilities £181,152. The company had an average of 0 employees. Figures are available for 6 financial years (2019/20–2024/25).

Control and charges

One person with significant control is registered.

Filing deadlines

The next accounts are due by 30 Jun 2027. The next confirmation statement is due by 22 Sep 2027.